Invited by Teacher Liu Chengbo, Professor Daniel Razansky from the Swiss Federal Institute of Technology in Zurich (ETH Zurich) visited Shenzhen Institutes of Advanced Technology for academic exchanges on October 23, 2019, and delivered an academic report titled "Multispectral optoacoustic tomography: a paradigm shift in biomedical research and clinical diagnostics". In the report, Professor Daniel Razansky mainly introduced the latest multispectral optoacoustic tomography technology of his team. This technology is based on the multi-wavelength excitation of tissues to visualize specific molecules in opaque living tissues, thus simultaneously transmitting structural, functional, metabolic, and molecular information through a single imaging modality. In addition, the report also shared how his team used a handheld multispectral optoacoustic tomography system to provide higher precision in the clinical diagnosis of patients with breast and skin lesions, lymph node metastasis, thyroid diseases, and inflammatory bowel disease, further realizing the clinical translation of optoacoustic imaging.

Professor Daniel Razansky communicated with the teachers and students of Shenzhen Institutes of Advanced Technology

Personal profiles:

Daniel Razansky is Full Professor of Biomedical Imaging with appointments at the Faculty of Medicine, University of Zurich (UZH) and Department of Information Technologies and Electrical Engineering, ETH Zurich. He is also the Director of the joint Animal Imaging Center of the ETH and UZH. He was previously the Director of Multi-Scale Functional and Molecular Imaging Laboratory and Professor of Molecular Imaging Engineering at the Technical University of Munich and Helmholtz Center Munich. He earned PhD in Biomedical Engineering and MSc in Electrical Engineering from the Technion – Israel Institute of Technology and completed postdoctoral training in bio-optics at the Harvard Medical School. Dr. Razansky’s Lab has pioneered and clinically translated a number of functional and molecular imaging technologies successfully commercialized worldwide, among them the multispectral optoacoustic tomography (MSOT) and hybrid optoacoustic ultrasound (OPUS). He has authored over 200 peer-review journal articles and holds 15 patented inventions in bio-imaging and sensing. He has delivered more than 150 invited, keynote, and plenary lectures worldwide. Among his recognitions are the German Innovation Prize and multiple awards from the ERC, NIH, DFG and HFSP. Dr. Razansky serves on Editorial Boards of a number of journals published by the Nature Publishing Group, IEEE and AAPM. He is an elected Council Member of the European Society for Molecular Imaging (ESMI), serves on the IEEE Technical Committee on Biomedical Imaging and Image Processing and has chaired numerous international conferences of the OSA, WMIS, ESMI, and IFMBE. He is also an elected Fellow of the OSA and SPIE.